The significance of correct dosing of hydroxychloroquine in clinical trials of COVID-19.

Sadasivam, Balakrishnan; Atal, Shubham; Ray, Avik; Sharma, Swati

Sadasivam, Balakrishnan; Atal, Shubham; Ray, Avik; Sharma, Swati.

Sadasivam B; Department of Pharmacology, All India Institute of Medical Sciences Bhopal, Bhopal 462020, Madhya Pradesh, India. Electronic address: balakrishnan.pharm@aiimsbhopal.edu.in.
Atal S; Department of Pharmacology, All India Institute of Medical Sciences Bhopal, Bhopal 462020, Madhya Pradesh, India. Electronic address: shubham.pharm@aiimsbhopal.edu.in.
Ray A; Department of Pharmacology, All India Institute of Medical Sciences Bhopal, Bhopal 462020, Madhya Pradesh, India. Electronic address: avik.jrpharma18@aiimsbhopal.edu.in.
Sharma S; Department of Pharmacology, All India Institute of Medical Sciences Bhopal, Bhopal 462020, Madhya Pradesh, India. Electronic address: dr.swatisharma@outlook.com.

Int J Infect Dis ; 100: 25-26, 2020 11.

Article in English | MEDLINE | ID: covidwho-1492091

Subject(s)

Coronavirus Infections; Pandemics; Pneumonia, Viral; Betacoronavirus; COVID-19; Coronavirus Infections/drug therapy; Dust; Humans; Hydroxychloroquine/adverse effects; SARS-CoV-2; COVID-19 Drug Treatment

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Pandemics Type of study: Prognostic study Limits: Humans Language: English Journal: Int J Infect Dis Journal subject: Communicable Diseases Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google